Cite

HARVARD Citation

    Zhang, D. (2020). Atezolizumab and bevacizumab: the revolutionary duo as a game changer in advanced hepatocellular carcinoma. Immuno-oncology technology. pp. 1-. [Online]. 
  
Back to record